32 participants
Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-10
- Start Date:
- 2026-06-10
- Completion:
- 2028-06-30
Conditions
- Hepatocellular Carcinoma (HCC)
Interventions
- DRUG
No Results Yet